| Osteopontin as a therapeutic target for cancer M Bandopadhyay, A Bulbule, R Butti, G Chakraborty, P Ghorpade, ... Expert opinion on therapeutic targets 18 (8), 883-895, 2014 | 144 | 2014 |
| RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer AS Yadav, NNV Radharani, M Gorain, A Bulbule, D Shetti, G Roy, T Baby, ... Nanoscale 12 (19), 10664-10684, 2020 | 77 | 2020 |
| Low dose of paclitaxel combined with XAV939 attenuates metastasis, angiogenesis and growth in breast cancer by suppressing Wnt signaling D Shetti, B Zhang, C Fan, C Mo, BH Lee, K Wei Cells 8 (8), 892, 2019 | 68 | 2019 |
| miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3 B Zhang, D Shetti, C Fan, K Wei Biological Research 52, 1-12, 2019 | 66 | 2019 |
| Erianin inhibits proliferation and induces apoptosis of HaCaT cells via ROS-mediated JNK/c-Jun and AKT/mTOR signaling pathways C Mo, D Shetti, K Wei Molecules 24 (15), 2727, 2019 | 38 | 2019 |
| Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated … L Yan, L Lu, F Hu, D Shetti, K Wei Royal Society Open Science 6 (6), 190360, 2019 | 32 | 2019 |
| Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer C Fan, F Kong, D Shetti, B Zhang, Y Yang, K Wei Biochemical and biophysical research communications 519 (2), 378-384, 2019 | 26 | 2019 |
| Applications of liquid biopsies in non-small-cell lung cancer M Pesta, D Shetti, V Kulda, T Knizkova, K Houfkova, M Sharif Bagheri, ... Diagnostics 12 (8), 1799, 2022 | 9 | 2022 |
| Nanomedicine: therapeutic applications and limitations G Ray, D Shetti, A Yadav, GC Kundu IGI Global, 2014 | 5 | 2014 |
| Oncogenic fusions in gliomas: An institutional experience J Polivka, M Svajdler, V Priban, J Mracek, P Kasik, P Martinek, N Ptakova, ... Anticancer Research 42 (4), 1933-1939, 2022 | 4 | 2022 |
| Nanomedicine: therapeutic applications and limitations R Gaurab, S Dattatrya, Y Amit Handbook of Research on Diverse Applications of Nanotechnology in …, 2015 | 4 | 2015 |
| Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma MS Bagheri, J Polivka, I Treskova, K Houfkova, T Knizkova, V Woznica, ... Anticancer Research 43 (2), 695-706, 2023 | | 2023 |
| Analysis of mutations in lung adenocarcinoma using the next generation sequencing V Kulda, J Polivka, M Svaton, T Vanecek, B Vankova, D Shetti, ... FEBS OPEN BIO 12, 102-103, 2022 | | 2022 |
| Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer. Diagnostics 2022, 12, 1799 M Pesta, D Shetti, V Kulda, T Knizkova, K Houfkova, MS Bagheri, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
| Pristane-induced mammary carcinomas D Shetti, BH Lee Methods in Cell Biology 163, 187-195, 2021 | | 2021 |
| Erianin inhibits proliferation and induces apoptosis of HaCaT cells via ROS-mediated JNK/c-Jun and AKT/mTOR signaling pathways. MCL Mo CanLong, D Shetti, WK Wei Kun | | 2019 |
| and Kun Wei L Yan, L Lu, F Hu, D Shetti | | 2019 |
| Therapeutic Study of Low Dose Paclitaxel Combined with XAV939 on Triple Negative Breast Cancer DM SHETTI 华南理工大学, 2019 | | 2019 |
Mahadeo GorainNCCS, PuneVerified email at nccs.res.in
